Texas court awards $41m to US biotech

Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Japanese pharma company wins arbitration over cancer drug

16 August 2022 Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.

Medtech

Texas jury says 3Shape must pay $12m over dental scanner

12 April 2022 A Texas jury has handed a $12 million victory to an Israeli company after finding that Danish company 3Shape’s dental scanner infringed one of its patents.

Americas

Texas uni wants Supreme Court to settle state sovereignty rules

12 March 2020 The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Texas court awards $41m to US biotech

More on this story

Editor's picks

Editor's picks

More features